P191 - Efficacy and safety in the use of infliximab in ulcerative colitis: analysis of a large single center cohort
✍ Scribed by M. Jürgens; S. Brand; R.T. Laubender; M. Weidinger; F. Hartl; J. Seiderer; J. Glas; J. Stallhofer; F. Beigel; M. Wetzke; S. Pfennig; C. Tillack; F. Schnitzler; B. Göke; T. Ochsenkühn
- Book ID
- 119636306
- Publisher
- Oxford University Press
- Year
- 2009
- Tongue
- English
- Weight
- 63 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1873-9946
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: The published experience regarding the use of tacrolimus in crohn's disease (cd) and ulcerative colitis (uc) refractory to more commonly used medical therapy has been fairly limited. our objective was to describe our experience with its use in a cohort of patients which, to our knowl
## Background: The aim of this study was to evaluate the shortand long-term safety experience of infliximab treatment in patients with Crohn's disease (CD) in clinical practice. ## Methods: The medical records of 297 consecutive patients with CD treated with infliximab at the Beth Israel Deacon